dma: yep, appreciated. Not meant to say that BDM is competing with BTA...just that BTA people may be interested in news on flu, especially since the CDC are involved. Vaccines are for prevention, relenza for cure...appreciated.
Here's how the wire services ran the story at 4:33pm. I've just talked to the AFR and they are going to try and get space to cover it in the paper tomorrow.
Sydney - Wednesday - August 30: (RWE Australian Business News) - BioDiem Ltd (ASX:BDM) has signed a cooperative research and development agreement (CRADA) with the US Centers for Disease Control and Prevention (CDC) to develop a cell culture candidate vaccine against avian influenza H5N1.
The agreement, co-signed with BioDiem's international partner Akzo Nobel's Nobilon, means BioDiem's live attenuated intranasal flu vaccine will be advanced through pre-clinical development at the CDC in its high-security laboratories.
According to experts at the World Health Organization, a live vaccine may offer better and broader protection in the event of a pandemic outbreak.
ENDS
BDM Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)